Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.23 USD | -9.72% | +0.68% | +62.77% |
May. 28 | Chardan Research Starts iBio With Buy Rating, $5 Price Target | MT |
May. 13 | IBio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+62.77% | 21.3M | |
+39.82% | 731B | |
+31.34% | 586B | |
-7.31% | 348B | |
+14.23% | 319B | |
+0.86% | 273B | |
+13.47% | 235B | |
-6.63% | 203B | |
+7.49% | 202B | |
+4.51% | 159B |
- Stock Market
- Equities
- IBIO Stock
- News iBio, Inc.
- iBio : Cantor Fitzgerald Starts IBio at Overweight With $3 Price Target